CL2004001192A1 - Un dispositivo de liberacion controlada que comprende: a) un nucleo con un agente activo y opcionalmente un excipiente y b) una pared que rodea al nucleo que tiene un pasaje preformado en ella, y que se rompe durante el uso para formar un segundo pas - Google Patents

Un dispositivo de liberacion controlada que comprende: a) un nucleo con un agente activo y opcionalmente un excipiente y b) una pared que rodea al nucleo que tiene un pasaje preformado en ella, y que se rompe durante el uso para formar un segundo pas

Info

Publication number
CL2004001192A1
CL2004001192A1 CL200401192A CL2004001192A CL2004001192A1 CL 2004001192 A1 CL2004001192 A1 CL 2004001192A1 CL 200401192 A CL200401192 A CL 200401192A CL 2004001192 A CL2004001192 A CL 2004001192A CL 2004001192 A1 CL2004001192 A1 CL 2004001192A1
Authority
CL
Chile
Prior art keywords
nucleo
nucleus
excipient
optionally
pass
Prior art date
Application number
CL200401192A
Other languages
English (en)
Inventor
Joaquina Vergez Juan A Faour
Original Assignee
Osmotica Argentina S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33476979&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2004001192(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Osmotica Argentina S A filed Critical Osmotica Argentina S A
Publication of CL2004001192A1 publication Critical patent/CL2004001192A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • External Artificial Organs (AREA)
CL200401192A 2003-05-22 2004-05-20 Un dispositivo de liberacion controlada que comprende: a) un nucleo con un agente activo y opcionalmente un excipiente y b) una pared que rodea al nucleo que tiene un pasaje preformado en ella, y que se rompe durante el uso para formar un segundo pas CL2004001192A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47281903P 2003-05-22 2003-05-22

Publications (1)

Publication Number Publication Date
CL2004001192A1 true CL2004001192A1 (es) 2005-03-28

Family

ID=33476979

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200401192A CL2004001192A1 (es) 2003-05-22 2004-05-20 Un dispositivo de liberacion controlada que comprende: a) un nucleo con un agente activo y opcionalmente un excipiente y b) una pared que rodea al nucleo que tiene un pasaje preformado en ella, y que se rompe durante el uso para formar un segundo pas

Country Status (8)

Country Link
EP (1) EP1629835A2 (es)
KR (2) KR20060015286A (es)
AR (1) AR047204A1 (es)
BR (1) BRPI0410546A (es)
CA (1) CA2526464C (es)
CL (1) CL2004001192A1 (es)
UY (1) UY28326A1 (es)
WO (1) WO2004103349A2 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101192722B1 (ko) 2003-04-24 2012-10-18 자고텍 아게 정해진 핵 위치를 가지는 서방성 정제
AR053986A1 (es) 2004-12-03 2007-05-30 Osmotica Pharmaceutical Argent Dispositivo osmotico que contiene amantadina y una sal osmotica
SI2049123T2 (sl) 2006-08-03 2016-10-28 Horizon Pharma Ag Zdravljenje revmatoznih bolezni z zadržanim sproščanjem glukokortikoida
WO2008065097A2 (en) * 2006-11-28 2008-06-05 Laboratorios Liconsa, S.A. Stabilized solid pharmaceutical composition of candesartan cilexetil
CA2670749A1 (en) 2006-12-05 2008-06-12 Landec Corporation Drug delivery
US8399007B2 (en) 2006-12-05 2013-03-19 Landec Corporation Method for formulating a controlled-release pharmaceutical formulation
CA2686394A1 (en) * 2007-05-11 2008-11-20 Santen Pharmaceutical Co., Ltd. Prophylactic or therapeutic agent for posterior ocular disease comprising non-ergot selective d2 receptor agonist as active ingredient
US8114883B2 (en) 2007-12-04 2012-02-14 Landec Corporation Polymer formulations for delivery of bioactive materials
US20120058185A1 (en) * 2009-05-22 2012-03-08 Pattanayak Durgaprasad Stable pharmaceutical compositions of olanzapine and process for their preparation
CN102935074B (zh) * 2011-08-15 2015-04-22 成都康弘药业集团股份有限公司 一种盐酸曲唑酮渗透泵控释片
KR102241487B1 (ko) 2013-02-20 2021-04-16 주식회사 종근당 제어방출 펠릿으로 된 약제학적 조성물
KR101647978B1 (ko) * 2014-03-17 2016-08-24 한국과학기술원 마이크로캡슐을 이용한 삼투압의 직접 측정 방법
WO2016132218A1 (en) 2015-02-20 2016-08-25 Osmotica Kereskedelmi Es Szolgaltato Kft Method of administering r-baclofen in an extended release dosage form

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3952741A (en) * 1975-01-09 1976-04-27 Bend Research Inc. Controlled release delivery system by an osmotic bursting mechanism
US4016880A (en) * 1976-03-04 1977-04-12 Alza Corporation Osmotically driven active agent dispenser
US4271113A (en) * 1978-04-17 1981-06-02 Alza Corporation Process for forming a passageway in an osmotic device
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Hydrogel-operated release devices
DD295760A5 (de) * 1989-01-31 1991-11-14 Martin-Luther-Universitaet Halle Wittenberg,De Arzneistoffreigabesystem mit kotrollierter wirkstoffreisetzung
ATE195252T1 (de) * 1993-04-23 2000-08-15 Novartis Erfind Verwalt Gmbh Wirkstoffabgabevorrichtung mit gesteuerter freigabe
AR026148A1 (es) * 2000-01-21 2003-01-29 Osmotica Argentina S A Dispositivo osmotico con pasaje preformado que aumenta de tamano
DE20100700U1 (de) * 2001-01-16 2001-03-22 Eugster Frismag Ag Romanshorn Kaffeegetränkzubereitungsautomat, insbesondere Espressoautomat
US20030143272A1 (en) * 2001-03-14 2003-07-31 Waterman Kenneth C. Pharmaceutical tablet and process for making thereof
ATE330586T1 (de) * 2001-03-14 2006-07-15 Pfizer Prod Inc Pharmazeutische tablette und eine verfahren zu deren herstellung
US6809288B2 (en) * 2001-05-23 2004-10-26 Osmotica Corp. Laser drilling system and method

Also Published As

Publication number Publication date
WO2004103349A3 (es) 2005-03-31
EP1629835A2 (en) 2006-03-01
KR20060015286A (ko) 2006-02-16
CA2526464A1 (en) 2004-12-02
WO2004103349A2 (es) 2004-12-02
KR20120105058A (ko) 2012-09-24
BRPI0410546A (pt) 2006-06-20
CA2526464C (en) 2010-06-29
AR047204A1 (es) 2006-01-11
UY28326A1 (es) 2004-06-30

Similar Documents

Publication Publication Date Title
CL2004001192A1 (es) Un dispositivo de liberacion controlada que comprende: a) un nucleo con un agente activo y opcionalmente un excipiente y b) una pared que rodea al nucleo que tiene un pasaje preformado en ella, y que se rompe durante el uso para formar un segundo pas
CL2015000383A1 (es) Kit farmaceutico que comprende al menos un agente farmaceutico activable capaz de causar un cambio celular predeterminado y por lo menos un agente modulador de la energía capaz de activar el agente farmaceutico.
CL2007003300A1 (es) Mecanismo accionador para usarse en un dispositivo de descarga de farmacos, comprende una envoltura que tiene un extremo proximal y uno distal, un miembro accionador dentro de la envoltura, un vastago de embolo, un medio giratorio engranado de modo l
CL2013003554A1 (es) Forma de dosificación farmacéutica sólida en forma de dispersión o solución sólida que comprende ritonavir, entre 50-80% en peso de al menos un polímero soluble en agua con una tg de al menos 50 °c, respecto del peso total de la forma de dosificación, y un tensoactivo (divisional de la sol.1844-2009 y esta divisional de la sol. 393-2006).
DE60328094D1 (de) Fluidausstossvorrichtung mit auslöser
AR058691A1 (es) Sonda microquirurgica
BRPI0815577A2 (pt) Peptídeo foxm1 e agente medicinal compreendendo o mesmo.
EP1958920A4 (en) FLUIDACTOR, THIS USING HEAT GENERATOR AND ANALYSIS DEVICE
ITTO20040390A1 (it) Composizione, in particolare per uso farmaceutico, ad azione antiossidante, antinfiammatoria ed immunostimolante.
BRPI0619911A2 (pt) composto, pró-droga, agente farmacêutico, e, uso do composto
NL1018728A1 (nl) Pulsbuiskoelinrichting.
AP2006003481A0 (en) 2-Substituted phenyl-5, 7- dihydrocarbyl-3, 7- di hydropyrrolo Ä2,3-dÜ pyrimidin-4- one derivatives,the preparation and the pharmaceutical use thereo f.
NL1027599A1 (nl) Röntgenapparaat met middelen voor opslaan van energie.
NO20000036L (no) Trykkfluidavgivende innretning
DE60125927D1 (de) Impfstoffe gegen hiv
UY27180A1 (es) Tornillo de fijación
ES1050920Y (es) Valvula de zona motorizada con un dispositivo de desconexion del actuador.
ITTO20050873A1 (it) Dispositivo per il comando di apertura di una valvola di intercettazione in un impianto di turbina a vapore provvisto di una linea di by-pass
焦宇焰 Grammatical Cohesion in the Translation between English and Chinese
EP2175271A4 (en) ASSAY PROCEDURE ON A CAT STICKED WITH A VACCINE AGAINST FELINES IMMUNODEFICIENCY AND ANTIGEN FOR USE IN THE TEST
ITMC20020004A1 (it) Forcella perfezionata,particolarmente per montain-bike,del tipo corredata di un dispositivo di blocco e sblocco della corsa di distenzione.
ITUD20030060A1 (it) Dispositivo e sistema di fermo alla battuta di una porta.
张文霞 A Linguistic Analysis of the Humor in Zhao Benshan's Sketches
金昌吉 et al. The Continuing Grammaticalization of Chinese Prepositions
Fukushima et al. Request Strategies in Role-Plays (English Linguistics and Literature)